Pictet Asset Management Sa Cytom X Therapeutics, Inc. Transaction History

Pictet Asset Management Sa

  • $83.4 Billion
  • Q2 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
BUY
$1.53 - $2.89 $470,291 - $888,328
307,380 Added 87.05%
660,495 $1.21 Million
Q1 2022

May 13, 2022
BUY
$2.67 - $4.68 $172,986 - $303,212
64,789 Added 22.47%
353,115 $943,000
Q4 2021

Feb 10, 2022
BUY
$3.87 - $7.39 $1.12 Million - $2.13 Million
288,326 New
288,326 $1.25 Million

Others Institutions Holding CTMX

# of Institutions
76
Shares Held
50.2M
Call Options Held
22.3K
Put Options Held
22.9K
View Full List

About CytomX Therapeutics, Inc.

CTMX Quotes by TradingView
  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $79.1M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email